Her medical history was notable for chronic myelomonocytic leukemia, diagnosed 6 years previously ... of disease was ultimately complicated by acute disseminated encephalomyelitis and death.

Adding venetoclax to decitabine-cedazuridine significantly enhanced response rates in patients with higher-risk ...

A high monocyte count is the most common sign of chronic myelomonocytic leukemia, a type of cancer that begins in the cells that produce blood in your bone marrow. A 2019 study suggests that a ...

编者按：2025年美国临床肿瘤学会年会（ASCO）将于美国东部时间（GMT-5）5月30日至6月3日在芝加哥召开。作为全球规模最大、学术水平最高、最具权威性的国际肿瘤会议之一，2025年ASCO年会将汇聚顶级肿瘤专家、学者和行业领袖，共探肿瘤领域的前 ...

I take a holistic approach. I think we need to make physicians who treat chronic myeloid leukemia treat the disease and make them more aware that you need to go beyond just looking at numbers.”— ...

The biotech has ambitions however to expand the use of the drug to other diseases that involve CD123, which include chronic myelomonocytic leukaemia (CMML), myelofibrosis and acute myeloid ...

Having too many or too few lymphocytes may be a sign of an acute or chronic infection or a sign of a severe disease, such as lymphoma, lupus, or leukemia. Lymphocytes are a type of leukocyte (white ...